CTOR
Price
$1.88
Change
+$0.01 (+0.53%)
Updated
Sep 5 closing price
Capitalization
147.34M
UTHR
Price
$390.60
Change
-$9.92 (-2.48%)
Updated
Sep 8, 12:29 PM (EDT)
Capitalization
18.11B
51 days until earnings call
Interact to see
Advertisement

CTOR vs UTHR

Header iconCTOR vs UTHR Comparison
Open Charts CTOR vs UTHRBanner chart's image
Citius Oncology
Price$1.88
Change+$0.01 (+0.53%)
Volume$146.85K
Capitalization147.34M
United Therapeutics
Price$390.60
Change-$9.92 (-2.48%)
Volume$200
Capitalization18.11B
CTOR vs UTHR Comparison Chart in %
Loading...
CTOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTOR vs. UTHR commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a Hold and UTHR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CTOR: $1.88 vs. UTHR: $400.52)
Brand notoriety: CTOR and UTHR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CTOR: 12% vs. UTHR: 132%
Market capitalization -- CTOR: $147.34M vs. UTHR: $18.11B
CTOR [@Pharmaceuticals: Generic] is valued at $147.34M. UTHR’s [@Pharmaceuticals: Generic] market capitalization is $18.11B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTOR’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • CTOR’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than CTOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTOR’s TA Score shows that 3 TA indicator(s) are bullish while UTHR’s TA Score has 7 bullish TA indicator(s).

  • CTOR’s TA Score: 3 bullish, 5 bearish.
  • UTHR’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than CTOR.

Price Growth

CTOR (@Pharmaceuticals: Generic) experienced а -13.36% price change this week, while UTHR (@Pharmaceuticals: Generic) price change was +31.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.09%. For the same industry, the average monthly price growth was +9.30%, and the average quarterly price growth was +88.50%.

Reported Earning Dates

UTHR is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.09% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($18.1B) has a higher market cap than CTOR($147M). CTOR YTD gains are higher at: 63.478 vs. UTHR (13.513). UTHR has higher annual earnings (EBITDA): 1.73B vs. CTOR (-25.48M). UTHR has more cash in the bank: 3.05B vs. CTOR (112). CTOR has less debt than UTHR: CTOR (3.8M) vs UTHR (200M). UTHR has higher revenues than CTOR: UTHR (3.08B) vs CTOR (0).
CTORUTHRCTOR / UTHR
Capitalization147M18.1B1%
EBITDA-25.48M1.73B-1%
Gain YTD63.47813.513470%
P/E RatioN/A15.63-
Revenue03.08B-
Total Cash1123.05B0%
Total Debt3.8M200M2%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTORUTHR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
27%
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
Bullish Trend 4 days ago
48%
Bullish Trend 4 days ago
68%
MACD
ODDS (%)
Bullish Trend 4 days ago
35%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
34%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 18 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
28%
Bearish Trend 4 days ago
67%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CTOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LFGP13.870.07
+0.51%
Ledyard Financial Group, Inc.
CJEWF1.90N/A
N/A
Chow Tai Fook Jewellery Group Limited
KURRF13.00N/A
N/A
Kuraray Co.
NXLLF1.60N/A
N/A
NUIX LTD
APTOF1.18-0.04
-3.48%
Aptose Biosciences. Inc.

CTOR and

Correlation & Price change

A.I.dvisor tells us that CTOR and TKNO have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and TKNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
+0.53%
TKNO - CTOR
14%
Poorly correlated
+2.83%
UTHR - CTOR
9%
Poorly correlated
+5.27%
RDHL - CTOR
7%
Poorly correlated
+16.54%
ALVO - CTOR
5%
Poorly correlated
+3.61%
SXTC - CTOR
5%
Poorly correlated
+16.67%
More